Company Filing History:
Years Active: 2006-2008
Title: Dramane Ibrahim Lainé: Innovator in Pharmaceutical Chemistry
Introduction
Dramane Ibrahim Lainé is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as p38 kinase inhibitors. With a total of 4 patents to his name, Lainé's work is recognized for its potential therapeutic applications.
Latest Patents
Lainé's latest patents include innovative compounds such as 5-Acylamino-1,1'-biphenyl-4-carboxamide derivatives. These compounds are designed for use as p38 kinase inhibitors, showcasing their potential in pharmaceutical applications. Another significant patent involves biphenylcarboxylic amide derivatives, which also serve as p38 kinase inhibitors. Both patents highlight the importance of these compounds in the development of new therapeutic agents.
Career Highlights
Dramane Ibrahim Lainé is currently associated with Glaxo Group Limited, where he continues to advance his research in pharmaceutical chemistry. His work has contributed to the understanding and development of new treatments for various diseases, particularly those related to inflammation and cancer.
Collaborations
Lainé has collaborated with esteemed colleagues such as Richard Angell and Nicola Mary Aston. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries in the field.
Conclusion
Dramane Ibrahim Lainé is a prominent figure in pharmaceutical innovation, with a focus on developing compounds that have significant therapeutic potential. His contributions to the field are marked by his patents and collaborations, which continue to influence the landscape of pharmaceutical research.